Medication treatments for panic disorder and social phobia.
In this Research Review, several recent clinical trials in panic disorder and social phobia are reviewed. First, two social phobia studies which used the monoamine oxidase type A inhibitors brofaromine and moclobemide are considered. Then, three panic disorder studies which used clonazepam, clomipramine or paroxetine, and citalopram are examined. These studies serve to strengthen the empirical research base regarding which treatments are useful in these disorders.
Stein
M B
MB
Department of Psychiatry (0985), University of California, San Diego, La Jolla 92093, USA. mstein@ucsd.edu
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001549:Benzamides / Q000008:administration & dosage; D001569:Benzodiazepines / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000008:administration & dosage; D002998:Clonazepam / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D016584:Panic Disorder / Q000188:drug therapy*; D017374:Paroxetine / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012920:Social Behavior Disorders / Q000188:drug therapy*
D000929:Antidepressive Agents, Tricyclic; D001549:Benzamides; D001569:Benzodiazepines; D015283:Citalopram; D002997:Clomipramine; D002998:Clonazepam; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors; D017374:Paroxetine; D010880:Piperidines; D017367:Selective Serotonin Reuptake Inhibitors; C038213:brofaromine